OINDP testing specialist Copley Scientific has announced upgrades to the company’s inhaler testing equipment range, including new products such as the Inhaler Testing Workstation (ITW) and updates to its TPK critical flow controllers, BAC 2100 breath actuated controllers, and BRS breathing simulators. The company has also updated its comprehensive inhaler testing brochure, which includes information about regulatory and pharmacopoeial guidelines for delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing.
According to the company, other additions include accessories for Copley’s automated shake and fire systems for use in nasal spray testing. Improvements to instruments and accessories include updated touchscreen controls and the use of quick release connectors on all equipment.
Copley Scientific CEO Mark Copley said, “Copley brings unrivaled expertise to every aspect of OINDP testing. We rigorously track changes in the regulatory landscape, and we listen to customers. The fully refreshed offering reflects these efforts. Our focus has been to make testing more straight forward and efficient, from bench space management to data analysis, equipment selection to test automation. The new brochure guides customers through the increasingly complex world of OINDP testing and explains how to use all our products effectively, whether testing a generic in accordance with product-specific guidance or refining a test set-up for better in vitro-in vivo correlations (IVIVCs).”
Copley added, “Continuous improvement is a Copley hallmark. Our new offering includes valuable upgrades that we’re confident can have a real impact on the day-to-day efficiency and integrity of OINDP testing. Whether you are looking for state-of-the-art equipment or insight on how to optimize testing strategies and lab practice, we can help.”
Read the Copley Scientific press release.
